Track the Shanghai Junshi Biosciences Co., Ltd. share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Health Care sector, Shanghai Junshi Biosciences Co., Ltd. has recorded 5 reports. Market capitalisation: €18.7bn. The latest transaction was reported on 8 April 2026 (Purchase). Among the most active insiders: Xiong Jun. The full history is free.
Analysts rate Shanghai Junshi Biosciences Co., Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: HK$28.93.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Shanghai Junshi Biosciences Co., Ltd. es una empresa biofarmacéutica centrada en la investigación y el desarrollo de fármacos innovadores. Se especializa en terapias biológicas para el tratamiento de enfermedades graves.